Home > Insider Trading > Filing (0001209191-15-035491)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1610618	Cidara Therapeutics Inc.	CDTX	Biological Products, (No Disgnostic Substances) (2836)	461537286

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1365617	J Patrick Heron	601 Union Street Suite 3200 Seattle WA 98101		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-04-20	155,645	$16.00	155,645	No	4	P	Indirect	By limited partnership
Common Stock	Acquisiton	2015-04-20	865,590	$0.00	1,021,235	No	4	C	Indirect	By limited partnership
Common Stock	Acquisiton	2015-04-20	44,355	$16.00	44,355	No	4	P	Indirect	By limited partnership
Common Stock	Acquisiton	2015-04-20	246,668	$0.00	291,023	No	4	C	Indirect	By limited partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By limited partnership
No	4	C	Indirect	By limited partnership
No	4	P	Indirect	By limited partnership
No	4	C	Indirect	By limited partnership

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Convertible Preferred Stock	Disposition	2015-04-20	865,590	$0.00	865,590	$0.00
Common Stock	Convertible Preferred Stock	Disposition	2015-04-20	246,668	$0.00	246,668	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Shares are held by Frazier Healthcare VII, LP. FHM VII LLC, or FHM, is the general partner of each of Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. FHM may be deemed to have sole voting and investment power over the shares beneficially owned by Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. The reporting person is one of the managing members of FHM and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
In connection with the Issuer's initial public offering, the preferred stock automatically converted into shares of the Issuer's common stock at the rate of 1 share of common stock for each 25.4 shares of preferred stock. The preferred stock had no expiration date.
Shares are held by Frazier Healthcare VII-A, LP. FHM VII LLC, or FHM, is the general partner of each of Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. FHM may be deemed to have sole voting and investment power over the shares beneficially owned by Frazier Healthcare VII, LP and Frazier Healthcare VII-A, LP. The reporting person is one of the managing members of FHM and disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.